Completed from United Kingdom
Just finished the course and loved it! It helped me finally nail down the basics of health‑technology assessment, which was exactly what I needed for my junior analyst role. The practical examples, like the QALY calculation for a new vaccine, were spot‑on and I could immediately use them in a project at work. The slides were clear and the extra video interviews with industry experts added a nice touch. All in all, a solid, enjoyable course that got me where I wanted to be.
The Pharmaceutical Health Economics course exceeded my expectations. The modules on cost‑effectiveness analysis directly aligned with my goal of preparing economic models for new drug submissions. I especially appreciated the hands‑on Excel workbook where we built a Markov model for a chronic disease; it gave me the confidence to present a full budget impact analysis to my manager. The reading materials were up‑to‑date, featuring recent NICE and FDA guidance, and the case studies were highly relevant to real‑world pharma strategy. Overall, the structured lectures and prompt instructor feedback made the learning experience both rigorous and rewarding.
I’m thrilled with how this course transformed my understanding of pharmaceutical economics! The deep dive into willingness‑to‑pay thresholds and the step‑by‑step guide to constructing a decision‑tree model gave me practical skills I could apply during my internship at a biotech firm. The instructor’s enthusiasm was infectious, and the supplementary datasets allowed us to practice real‑world pricing scenarios. The course material is current, with references to recent Indian health policy reforms, making it highly relevant for anyone in the region. I feel fully equipped to contribute to health‑economic evaluations now.
The Pharmaceutical Health Economics program was exceptionally thorough. My learning goal was to understand the intersection of drug pricing and public health outcomes, and the curriculum delivered on that promise through detailed modules on budget impact analysis and sensitivity testing. I found the case study on the rollout of antiretroviral therapy in sub‑Saharan Africa particularly enlightening; it equipped me with the ability to assess cost‑utility in resource‑limited settings. The course pack included recent WHO guidelines and peer‑reviewed articles, ensuring both academic rigor and practical relevance. The instructor’s detailed feedback on assignments reinforced my grasp of the concepts, making the overall experience highly satisfactory.
